Merck, Incyte IDO inhibitor fails late-stage trial
Thursday, July 5, 2018 - 18:22
in Health & Medicine
Result casts shadow over other similar-acting cancer immunotherapy drug candidates
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via